Cargando…
Efficacy and Safety of Quetiapine for Pediatric Bipolar Depression: A Systematic Review of Randomized Clinical Trials
Quetiapine is a second-generation antipsychotic (SGA) approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia, mania, and aggression in children and adolescents. It is also commonly used as an off-label medication to treat children and adolescents with bipolar depressio...
Autores principales: | Srinivas, Sushma, Parvataneni, Tarun, Makani, Ramkrishna, Patel, Rikinkumar S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331915/ https://www.ncbi.nlm.nih.gov/pubmed/32637286 http://dx.doi.org/10.7759/cureus.8407 |
Ejemplares similares
-
Perspective on Melatonin Use for Sleep Problems in Autism and Attention-Deficit Hyperactivity Disorder: A Systematic Review of Randomized Clinical Trials
por: Parvataneni, Tarun, et al.
Publicado: (2020) -
Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008) -
Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials
por: Ogasawara, Masaya, et al.
Publicado: (2022) -
Quetiapine for acute bipolar depression: a systematic review and meta-analysis
por: Suttajit, Sirijit, et al.
Publicado: (2014) -
Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
por: Hardoy, Maria Carolina, et al.
Publicado: (2007)